Activity stemming from abemaciclib plus letrozole was most pronounced in chemotherapy-naive patients with advanced endometrioid endometrial carcinoma.
Quincy Attobrah
Advertisement
Articles by Quincy Attobrah
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Grants Orphan Drug Designation to Tovecimig for Biliary Tract Cancer
2
FDA Issues Second CRL for RP1/Nivolumab in Advanced Melanoma
3
Personalized Treatment Plans for Certain Patients with BRCA-Mutated mCRPC
4
Relacorilant/Nab-Paclitaxel Reduces Risk of Death by 35% in Platinum-Resistant Ovarian Cancer
5